What Is Organogenesis Holdings Inc. (ORGO) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Organogenesis Holdings Inc. at its current price of $2.34. The composite intrinsic value is estimated at $1.92 (-17.8% average return), with 7 models flagging overvaluation risk. Model dispersion is worth noting: Regime Cross targets $4.31 (+84.2%), versus ML-RIV at $0.21 (-91.0%). This +175.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ORGO?
12 of 13 models are currently active for ORGO. Of these, 5 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates ORGO's intrinsic value at $0.40, implying -82.9% downside from the current price. See which stocks rank higher →
How Does ORGO Rank in Pharmaceutical Preparations?
Among 469 Pharmaceutical Preparations stocks, ORGO ranks #48 by Quality of Company score. CirclFi's QOC score of 7.5/10 evaluates 32 fundamental signals. A score of 7.5 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Organogenesis Holdings Inc. operates in a sector where revenue per drug is a critical driver of valuation. Investors evaluating ORGO should weigh these sector-specific dynamics alongside our model-derived fair values.
Is ORGO a Value Trap?
CirclFi's Value Trap algorithm assigns ORGO a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Organogenesis Holdings Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Organogenesis Holdings Inc.'s fundamental quality profile registers 7.5/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +175.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ORGO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ORGO's 12 active models, average confidence is 34%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad